| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/20/2008 | EP1889619A1 Use of thiadiazolidine-derived compounds as neurogenic agents |
| 02/20/2008 | EP1889611A1 Sugar-coated tablet |
| 02/20/2008 | EP1888646A2 Antibodies directed against the myelin basic protein recognising an epitope of cd64 and their use as immunosuppressants |
| 02/20/2008 | EP1888627A2 Nucleic acids and polypeptides that are useful in controlling neuronal regeneration |
| 02/20/2008 | EP1888626A2 A therapeutic agent for ab related disorders |
| 02/20/2008 | EP1888618A2 Analogs of glycyl-prolyl-glutamate |
| 02/20/2008 | EP1888594A2 Gabaergic agents to treat memory deficits |
| 02/20/2008 | EP1888586A2 2,3-substituted fused bicyclic pyrimidin-4(3h)-ones which modulate the function of the vanilloid-1 receptor (vr1) |
| 02/20/2008 | EP1888573A1 Thiazole derivatives and use thereof |
| 02/20/2008 | EP1888546A1 Thiazole derivatives and use thereof |
| 02/20/2008 | EP1888542A1 Substituted spiro-compounds and the use thereof for producing medicaments |
| 02/20/2008 | EP1888538A1 (3,4-dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amines having an activity on the 5-ht receptor |
| 02/20/2008 | EP1888518A1 Novel 8-sulfonyl-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor |
| 02/20/2008 | EP1888517A1 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor |
| 02/20/2008 | EP1888120A2 Novel salts of conjugated psychotropic drugs and processes of preparing same |
| 02/20/2008 | EP1888100A2 Use of il-18bp isoforms for the treatment and/or prevention of neurological inflammatory diseases |
| 02/20/2008 | EP1888094A2 Amylin and amylin agonists for treating psychiatric diseases and disorders |
| 02/20/2008 | EP1888080A1 Pharmaceutical compositions of a neuroactive steroid and usees thereof |
| 02/20/2008 | EP1888064A1 Benztropinamine analogs as dopamine uptake inhibitors |
| 02/20/2008 | EP1888059A2 Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomakers |
| 02/20/2008 | EP1888056A2 Use of ladostigil for the treatment of multiple sclerosis |
| 02/20/2008 | EP1613312B1 Benzimidazole derivatives and their use for modulating the gaba a receptor complex |
| 02/20/2008 | EP1572211B1 Therapeutic applications of 2-substituted 4-heteroarylpyrimidines |
| 02/20/2008 | EP1555022B1 Sustained release formulation of acetaminophen and tramadol |
| 02/20/2008 | EP1448561B1 Beta 3 adrenergic agonists |
| 02/20/2008 | EP1436271B1 Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 02/20/2008 | EP1406667B1 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals |
| 02/20/2008 | EP1383747B1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 02/20/2008 | EP1177166B1 Process for preparing (1r,2s,4r) -(-)-2- (2'- n,n-dimethylamino -ethoxy) -2- phenyl -1,7,7-tri- methyl -bicyclo 2.2.1 heptane and pharmaceutically acceptable acid addition salts thereof |
| 02/20/2008 | EP1071422B1 Association of Riluzole and levodopa for the treatment of Parkinson disease |
| 02/20/2008 | EP0644877B1 Substituted-hexahydrobenzo a phenanthridines |
| 02/20/2008 | CN101128484A Compositions and methods relating to anti IGF-1 receptor antibodies |
| 02/20/2008 | CN101128460A Tricyclic delta-opioid modulators |
| 02/20/2008 | CN101128458A Tricyclic delta-opioid modulators |
| 02/20/2008 | CN101128451A Derivatives of n-[(4,5-diphenyl-2-thienyl)methyl]amine, their preparations and therapeutic application |
| 02/20/2008 | CN101128447A Diarylmethyl piperazine derivatives, preparations thereof and uses thereof |
| 02/20/2008 | CN101128435A Pyrazolone compounds as metabotropic glutamate receptor agonists for the treatment of neurological and psychiatric disorders |
| 02/20/2008 | CN101128433A Isoquinoline derivatives as calpain inhibitors |
| 02/20/2008 | CN101128431A Novel quinoline derivatives as potassium ion channel openers |
| 02/20/2008 | CN101128430A Pyridine compounds for the treatment of prostaglandin mediated diseases |
| 02/20/2008 | CN101128429A Nk1拮抗物 Nk1 antagonist |
| 02/20/2008 | CN101128203A Composition comprising ocaperidone |
| 02/20/2008 | CN101128198A Combination of sabcomeline with a neuroleptic agent to treat psychotic disorders |
| 02/20/2008 | CN101128194A Preventive antistress agent |
| 02/20/2008 | CN101128191A Dosage form containing oxycodone and naloxone |
| 02/20/2008 | CN101126098A Small disturbance RNA molecule expression carrier for differentially inhibiting GFAP protein expression and its construction method and use thereof |
| 02/20/2008 | CN101125890A Monoclonal antibody for resisting bovine prion protein and application thereof |
| 02/20/2008 | CN101125882A Recombination PAC1 receptor agonist RMMAX and its expression method and application |
| 02/20/2008 | CN101125870A Synthesis for 3-(4-beta-D-pyranalloseglycoside-phenyl)-4-aryl-5-aryl-1,2,4-oxadiazoline |
| 02/20/2008 | CN101125848A A process for preparing duloxetine and intermediates for use therein |
| 02/20/2008 | CN101125205A Polyethylene decorative nevin fibrinolytic enzyme and its preparation method |
| 02/20/2008 | CN101125181A Plaster for treating facial neuroparalysis |
| 02/20/2008 | CN101125170A Gastric floating composition for sobering up |
| 02/20/2008 | CN101125153A Acanthopanax root granule and its preparation method |
| 02/20/2008 | CN101125137A Pharmaceutical salts |
| 02/20/2008 | CN101125131A Method for preparing flupentixol and melitracen capsule |
| 02/20/2008 | CN101125128A Sustained-release tablet composition of pramipexole |
| 02/20/2008 | CN100369919C Tricyclic protein kinase inhibitors |
| 02/20/2008 | CN100369916C 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity |
| 02/20/2008 | CN100369915C 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity |
| 02/20/2008 | CN100369912C Heteroaryl substituted fused bicyclic heteroaryl compounds as GABAA receptor ligands |
| 02/20/2008 | CN100369898C Nicotinamide derivates useful as p38 inhibitors |
| 02/20/2008 | CN100369894C Nitric oxide synthase inhibitor phosphate salt |
| 02/20/2008 | CN100369891C HIF hydroxylase inhibitors |
| 02/20/2008 | CN100369888C N-alkanoylphenylalanine derivatives |
| 02/19/2008 | US7332644 Screening for a developmental promoter or a developmental suppressor of oligodendrocytes, or a promoter or a suppressor of myelinogenesis, diagnostic for neuropsychiatric disorders |
| 02/19/2008 | US7332521 Substituted indoles |
| 02/19/2008 | US7332517 1-(1H-indol-3-ylmethyl)-3-(4-nitrophenyl)-5-[2-(4-phenyl-1H-imidazol-2-yl)ethyl]-2thioxo-4imidazolidinone; somastatin receptor affinity; acromegaly, hypophyseal adenomas, endocrine gastroenteropancreatic tumors, as carcinoid syndrome and gastrointestinal bleeding |
| 02/19/2008 | US7332510 Metabotropic glutamate (mGluR5) receptor mediated disorders; psychosis, epilepsy, schizophrenia, Alzheimer' disease, cognititve disorders, memory deficits, chronic and acute pain; containing pyridin-4-ylethynyl functionality |
| 02/19/2008 | US7332507 Cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters; treating pain, neurodegeneration, inflammation, and drug or alcohol withdrawal symptoms; 3-benzimidazole, indole or triazole substituted |
| 02/19/2008 | US7332506 Substituted-3-indolyl-4-piperidino-alkyl heterocycles for the treatment of depression |
| 02/19/2008 | US7332504 Heterocyclic substituted aminoazacycles useful as central nervous system agents |
| 02/19/2008 | US7332503 Aporphine esters and their use in therapy |
| 02/19/2008 | US7332497 Pyrazolopyrimidines as therapeutic agents |
| 02/19/2008 | US7332495 Aralkyl-ketone piperazine derivatives and their uses as new antalgic or ataractic agent |
| 02/19/2008 | US7332492 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by NP Y5 receptor |
| 02/19/2008 | US7332486 9-(4-carboxyphenyl)-6-cyclopropylamino-2-trifluoromethylpurine; side effect reduction; cognition activator, antidepressants, neuroleptic agent, schizophrenia, Alzheimer's disease, schizophrenia, Parkinson's, Huntington's, Pick's, Creutzfeld-Jakob, cardiovascular diseases, HIV |
| 02/19/2008 | US7332483 3-(5-benzamido-2-chlorophenyl)-7-methoxy-3,4-dihydroquinazolin-4-one;cytokines (tumor necrosis factor and interleukins) inhibitor; antiinflammatory agent, rheumatoid arthritis, osteoarthritis, psoriasis, chronic obstructive pulmonary disease |
| 02/19/2008 | US7332473 derived from a PACAP or VIP peptide; can inhibit tautomerization in a solution; regressive neurodegenerative diseases, erectile dysfunction, and bronchial asthma; inhibited isomerization and high stability during the production and storage |
| 02/19/2008 | US7332185 Component I selected from alpha acids and beta acids and component II selected from alpha acids, beta acids, essential oils, fats and waxes; specific inhibition of cyclooxygenase-2 with little effect on cyclooxygenase-1 |
| 02/19/2008 | US7332177 Administering melatonin to ameliorate or prevent symptoms of hypertension developing in a patient who is resistant to the antihypertensive effect of an antihypertensive compound |
| 02/19/2008 | CA2481723C 5ht2c receptor modulators |
| 02/19/2008 | CA2338901C Prevention of migraine recurrence |
| 02/19/2008 | CA2328927C Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 02/19/2008 | CA2301723C Butyrate derivatives in the treatment of fibromyalgia and chronic fatigue syndrome |
| 02/19/2008 | CA2273240C Compositions and methods for treating or preventing inflammatory diseases |
| 02/19/2008 | CA2265893C Oily patches for external use containing diclofenac sodium |
| 02/19/2008 | CA2226582C Non-allosteric gabaa agonists for treating sleep disorders |
| 02/19/2008 | CA2173976C Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 02/19/2008 | CA2113726C Use of tetrahydrocarbazone derivatives as 5ht1 receptor agonists |
| 02/14/2008 | WO2008019395A2 Compounds for improving learning and memory |
| 02/14/2008 | WO2008019276A2 Solid forms of (3'-chlorobiphenyl-4-yl)(1-(pyrimidin-2-yl)piperidin-4-yl)methanone and methods of their use |
| 02/14/2008 | WO2008019240A2 3, 6-bridged tylosin derivatives |
| 02/14/2008 | WO2008018872A1 Therapeutic methods of using estrogen compositions |
| 02/14/2008 | WO2008018827A1 Benzimidazole derivatives useful in treatment of vallinoid receptor trpv1 related disorders |
| 02/14/2008 | WO2008018815A1 Mono-and divalent salts of n-(5-hydroxynicotinoil)-l-glutaminic acid exhibiting psychotropic (antidepressant and anxyolytic), neuroprotective, heroprotective and cerebroprotective action |
| 02/14/2008 | WO2008018655A1 Novel thiazole-based compound and inhibitor of t-type calcium channel containing the same |
| 02/14/2008 | WO2008018600A1 THERAPEUTIC AGENT FOR ACCELERATION OF SPINAL NERVE REPAIR COMPRISING GHRELIN, DERIVATIVE THEREOF OR SUBSTANCE CAPABLE OF ACTING ON GHS-R1a AS ACTIVE INGREDIENT |
| 02/14/2008 | WO2008018597A1 Therapeutic agent for acceleration of spinal nerve repair comprising desacyl ghrelin or derivative thereof as active ingredient |
| 02/14/2008 | WO2008018472A1 Novel monoclonal antibody and use of the same |